These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2372718)

  • 21. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Brakes and levers of mobilization concerning cardiovascular prevention].
    Turpin G
    Ann Cardiol Angeiol (Paris); 1995; 44(6):284-7. PubMed ID: 7574360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases.
    Puska P; Vartiainen E; Tuomilehto J; Salomaa V; Nissinen A
    Bull World Health Organ; 1998; 76(4):419-25. PubMed ID: 9803593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diet and cardiovascular diseases.
    Kromhout D
    J Nutr Health Aging; 2001; 5(3):144-9. PubMed ID: 11458283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Clin Pharmacol; 2009 Aug; 49(8):947-56. PubMed ID: 19602720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changing pattern of cardiovascular diseases in China.
    Yao C; Wu Z; Wu Y
    World Health Stat Q; 1993; 46(2):113-8. PubMed ID: 8303905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease.
    Hengstenberg C; Holmer SR; Mayer B; Engel S; Schneider A; Löwel H; Riegger GA; Schunkert H
    Eur Heart J; 2001 Jun; 22(11):926-33. PubMed ID: 11428816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of classical risk factors. A public health and health policy task].
    Keil U
    Arzneimittelforschung; 1990 Mar; 40(3A):388-94. PubMed ID: 2185772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Strategy of the french cardiology association in the prevention of coronary disease].
    Vacheron A
    Arch Mal Coeur Vaiss; 1992 Feb; 85(2):165-7. PubMed ID: 1562217
    [No Abstract]   [Full Text] [Related]  

  • 36. The key issues in preventive cardiology.
    Hansson L
    Blood Press Suppl; 1992; 4():7-10. PubMed ID: 1345336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular health of the brazilian male: the view of the Brazilian Society of Cardiology.
    Chagas AC; Zilli EC; Ferreira JF; Moretti MA; Ramos RF
    Arq Bras Cardiol; 2009 Dec; 93(6):541-4, 584-7. PubMed ID: 20379629
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictive Accuracy of the European Society of Cardiology SCORE Among French People.
    Bérard E; Séguro F; Bongard V; Dallongeville J; Arveiler D; Amouyel P; Wagner A; Ruidavets JB; Ferrières J
    J Cardiopulm Rehabil Prev; 2016; 36(1):38-48. PubMed ID: 26468633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology.
    Laslett LJ; Alagona P; Clark BA; Drozda JP; Saldivar F; Wilson SR; Poe C; Hart M
    J Am Coll Cardiol; 2012 Dec; 60(25 Suppl):S1-49. PubMed ID: 23257320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polish Forum for Prevention: a response to the European Society of Cardiology 'call for action' in Poland.
    Podolec P; Kopec G; Pajak A; Torbicki A; Zdrojewski T; Rynkiewicz A
    Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):250. PubMed ID: 20389221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.